Truvian Sciences, a San Diego startup that’s developing a benchtop blood testing machine to bring rapid, point-of-care health screening to local pharmacies, medical clinics and corporate wellness centers, has raised $105 million in a third round of venture capital funding
Brittany Meiling of the San Diego Union Tribune explores how San Diego’s employers are ensuring a safe return back to the office. Truvian CCO Katherine Atkinson shares how Truvian has doubled down on our company culture initiatives during to keep the teams connected to our mission and each other. Read more.
San Diego life sciences executive Jeff Hawkins is trying to bring credibility back to field rocked by scandal